RAC 2.20% $1.78 race oncology ltd

Ann: Impressive Preclinical Bisantrene Breast Cancer Results, page-132

  1. 381 Posts.
    lightbulb Created with Sketch. 70
    Great interview & very informative. Possible Stage 2 trials early next year & more information coming from the AGM. Great company superbly ran by all & always considering the shareholders. Keep up the good work. Onwards & Upwards!
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.